These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51 related articles for article (PubMed ID: 38374)
1. [Heart rate and metabolic values in long-lasting automobile trips under beta-receptor blockade (Bunitrolol)]. Keul J; Huber G; Lehmann M Med Welt; 1979 Jul; 30(28):1080-5. PubMed ID: 38374 [No Abstract] [Full Text] [Related]
2. [Comparable ergometric examinations before and after administration of practolol and bunitrolol (author's transl)]. Pozenel H Wien Klin Wochenschr; 1975 Jan; 87(1):19-25. PubMed ID: 236621 [TBL] [Abstract][Full Text] [Related]
3. [Effect of a new beta-receptor blockader (Bunitrolol) on the circulation and metabolism during extreme stress conditions]. Keul J; Huber G; Kindermann W; Burmeister P; Petersen KG Med Welt; 1976 Feb; 27(9):437-43. PubMed ID: 4692 [No Abstract] [Full Text] [Related]
4. [Effect of bunitrolol on heart rate, metabolic parameters during physical exercise, and performance]. Keul J; Lehmann M; Wybitul K Arzneimittelforschung; 1981; 31(11):1948-53. PubMed ID: 6119096 [TBL] [Abstract][Full Text] [Related]
5. [Lowering the heart rate in tachycardiac atrial fibrillation by beta receptor blockade]. Horn HG; Neuss H; Schlepper M; Mitrovic V; Stämmler G Med Klin; 1980 Sep; 75(20):721-5. PubMed ID: 6106885 [TBL] [Abstract][Full Text] [Related]
6. [The influence of a long-term cardioselective and noncardioselective beta-receptorblockade on blood pressure, O2-uptake and carbohydrate metabolism. Ergometric investigations in hypertensive patients (author's transl)]. Franz IW; Lohmann FW Z Kardiol; 1979 Jul; 68(7):503-9. PubMed ID: 473853 [TBL] [Abstract][Full Text] [Related]
7. Antihypertensive effect of intravenously and orally administered bunitrolol (Kö 1366). Okabayashi T; Naito S; Arakawa K Arzneimittelforschung; 1979; 29(9):1417-21. PubMed ID: 42418 [TBL] [Abstract][Full Text] [Related]
8. Dose response and frequency of administration of atenolol in essential hypertension--once daily treatment with beta-blockade. Marshall AJ; Barritt DW; Harry JD Postgrad Med J; 1977; 53 Suppl 3():168-72. PubMed ID: 337271 [No Abstract] [Full Text] [Related]
9. [Beta blocking effects of butofilolol in standard exercise tests in the healthy subjects]. Letac B; Bousnina A; Cribier A; Berland J Ann Cardiol Angeiol (Paris); 1982; 31(5):405-8. PubMed ID: 6130740 [No Abstract] [Full Text] [Related]
10. A double blind cross-over comparison of bunitrolol and placebo in the treatment of angina pectoris. Jonker JJ; de Klerk J; den Ottolander GJ Arzneimittelforschung; 1981; 31(7):1140-2. PubMed ID: 6115654 [TBL] [Abstract][Full Text] [Related]
11. [Driving behavior of cardiovascular patients as affected by beta receptor blockers]. Schmidt U; Hoburg A; Brendemühl D; Delbeck HW; Buck W; Engels K Med Klin; 1980 Dec; 75(26):913-6. PubMed ID: 7464643 [TBL] [Abstract][Full Text] [Related]
12. [Effects of the new adrenergic beta receptor blockader Kö 1366 (Bunitrolol) on blood circulation]. Klempt HW; Bender F Arzneimittelforschung; 1973 Aug; 23(8):1064-70. PubMed ID: 4148873 [No Abstract] [Full Text] [Related]
13. [Field study: long-term antihypertensive therapy with the beta blocker nadolol in a once-a-day dosage - an outpatient study of Swiss medical practices]. Bertel O; Conen D; Renggli I Schweiz Rundsch Med Prax; 1983 Feb; 72(8):264-8. PubMed ID: 6132374 [No Abstract] [Full Text] [Related]
14. Effects of bunitrolol on myocardial contractility and left ventricular myosin isoenzyme pattern. Takeda N; Nakamura I; Hatanaka T; Ohkubo T; Nagano M Arzneimittelforschung; 1988 Sep; 38(9):1280-2. PubMed ID: 2906244 [TBL] [Abstract][Full Text] [Related]
15. [Long term comparison between atenolol and a depot form of propranolol hydrochloride on the heart rate and blood pressure at rest and during physical work in normal subjects]. Wink K; Weisser P Arzneimittelforschung; 1980; 30(8):1298-301. PubMed ID: 7192146 [TBL] [Abstract][Full Text] [Related]
16. Physical performance and muscle metabolism during beta-adrenergic blockade in man. Kaiser P Acta Physiol Scand Suppl; 1984; 536():1-53. PubMed ID: 6151777 [TBL] [Abstract][Full Text] [Related]
17. [Effect of selective and non-selective adrenoceptor blockade during physical work on energy metabolism and sympatho-adrenergic system (author's transl)]. Lehmann M; Keul J; Wybitul K; Fischer H Arzneimittelforschung; 1982; 32(3):261-6. PubMed ID: 6123330 [TBL] [Abstract][Full Text] [Related]
18. Slow-release metoprolol in angina pectoris. A comparative study of a cardioselective beta-blocking drug, metoprolol, in ordinary and slow-release tablets (Durules) in the treatment of angina pectoris. Uusitalo AJ; Keyriläinen O Ann Clin Res; 1979 Oct; 11(5):199-204. PubMed ID: 44671 [TBL] [Abstract][Full Text] [Related]
19. Once daily atenolol (Tenormine) in the treatment of angina pectoris. Observations on clinical efficacy, pharmacokinetics and pharmacodynamics. Majid PA; van der Vijgh WJ; de Feijter PJ; Wardeh R; van der Wall EE; Roos JP Eur J Cardiol; 1979 Jun; 9(6):419-35. PubMed ID: 381009 [No Abstract] [Full Text] [Related]
20. The metabolic demands of driving for drivers with type 1 diabetes mellitus. Cox DJ; Gonder-Frederick LA; Kovatchev BP; Clarke WL Diabetes Metab Res Rev; 2002; 18(5):381-5. PubMed ID: 12397580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]